ULTRAGENYX PHARMACEUTICAL INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.56 USD | +3.14% |
|
+0.26% | -7.25% |
| 05:28pm | Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $47 From $48, Keeps Neutral Rating | MT |
| 05-02 | Transcript : Ultragenyx Pharmaceutical Inc., Q1 2024 Earnings Call, May 02, 2024 |
MarketScreener Editorial Features
Search
 | Investors take a wait-and-see attitude ahead of central bank meetings | July 20, 2022 at 03:27 pm |
 | ANALYST RECOMMENDATIONS : Alphabet, Amazon, Chevron, Rio Tinto, Netflix... | July 20, 2022 at 10:41 am |
 | Today on Wall Street: Is the economic recovery still on track? | August 04, 2021 at 02:24 pm |
 | ANALYST RECOMMENDATIONS : Chevron, Clorox, Nikola, Rambus, Rio Tinto.... | August 04, 2021 at 10:08 am |
 | Today on Wall Street: The start of a new phase | June 30, 2021 at 01:47 pm |
 | ANALYST RECOMMENDATIONS : Apple, FedEx, Intellia Therapeutics, Reckitt Benckiser, XPO Logistics... | June 30, 2021 at 11:12 am |
No results for this search
- Stock Market
- Equities
- RARE Stock
- News Ultragenyx Pharmaceutical Inc.
- MarketScreener Editorial Features
